Biochemical characterization of acyl-coenzyme A synthetases involved in mycobacterial steroid side-chain catabolism and molecular design: synthesis of an anti-mycobacterial agent
- 28 Downloads
The metabolism of host cholesterol by Mycobacterium tuberculosis is an important factor for both its virulence and pathogenesis. However, the rationale for this cholesterol metabolism has not been fully understood yet. In the present study, we characterized several previously undescribed acyl-CoA synthetases that are involved in the steroid side-chain degradation in Mycobacterium smegmatis, and an analogue of intermediate from steroid degradation, 5′-O-(lithocholoyl sulfamoyl) adenosine (LCA-AMS), was successfully designed and synthesized to be used as a specific anti-mycobacterial agent. The acyl-CoA synthetases exhibited strong preferences for the length of side chain. FadD19 homologs, including FadD19 (MSMEG_5914), FadD19-2 (MSMEG_2241), and FadD19-4 (MSMEG_3687), are unanimously favorable cholesterol with a C8 alkanoate side chain. FadD17 (MSMEG_5908) and FadD1 (MSMEG_4952) showed high preferences for steroids, containing a C5 alkanoate side chain. FadD8 (MSMEG_1098) exhibited specific activity toward cholestenoate with a C8 alkanoate side chain. An acylsulfamoyl analogue of lithocholate, 5′-O-(lithocholoyl sulfamoyl) adenosine (LCA-AMS), was designed and synthesized. As expected, the intermediate analogue not only specifically inhibited those steroid-activated acyl-CoA synthetases, but also selectively inhibited the growth of mycobacterial species, including M. tuberculosis, M. smegmatis, and Mycobacterium neoaurum. Overall, our research advanced our understanding of mycobacterial steroid degradation and provided new insights to develop novel mechanism-based anti-mycobacterial agents.
KeywordsBiochemical characterization Acyl-coenzyme A synthetases Steroid side-chain degradation Anti-mycobacterial agent
This study was funded by the National Natural Science Foundation of China (no. 31571285), the Sichuan provincial Science & Technology Department (2012JY0067), and the Sichuan Provincial Department of Education (17ZA0323), College student innovation, and entrepreneurship training program (201310636026).
YN, FG, and YY did all the biological and analytical work on acyl-coenzyme A synthetases. YR and XZ did the synthetic work. WL conceived and designed the project. GC, DW, FL, and XY prepared the purified acyl-coenzyme A synthetases. All the authors participated in writing the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest with the contents of this article.
- Geize RVD, Yam K, Heuser T, Wilbrink MH, Hara H, Anderton MC, Sim E, Dijkhuizen L, Davies JE, Mohn WW (2007) A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc Natl Acad Sci USA 104(6):1947CrossRefGoogle Scholar
- Kendall SL, Withers M, Soffair CN, Moreland NJ, Gurcha S, Sidders B, Frita R, Bokum AT, Besra GS, Lott JS (2007) A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis. Mol Microbiol 65(3):684–699CrossRefGoogle Scholar
- Meng Y, Rui L, Guja KE, Wipperman M, Clair JRS, Bonds AC, Garciadiaz M, Sampson NS (2015) Unraveling cholesterol catabolism in Mycobacterium tuberculosis: ChsE4-ChsE5 α2β2 Acyl-CoA dehydrogenase initiates β-oxidation of 3-Oxo-cholest-4-en-26-oyl CoA. Acs Infect Dis 1(2):110–125CrossRefGoogle Scholar
- Rodríguezgarcía A, Fernándezalegre E, Morales A, Solalanda A, Lorraine J, Macdonald S, Dovbnya D, Smith MC, Donova M, Barreiro C (2016) Complete genome sequence of ‘Mycobacterium neoaurum’ NRRL B-3805, an androstenedione (AD) producer for industrial biotransformation of sterols. J Biotechnol 224:64–65CrossRefGoogle Scholar
- Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New YorkGoogle Scholar
- Soto-Ramirez MD, Aguilar-Ayala DA, Garcia-Morales L, Rodriguez-Peredo SM, Badillo-Lopez C, Rios-Muñiz DE, Meza-Segura MA, Rivera-Morales GY, Leon-Solis L, Cerna-Cortes JF (2017) Cholesterol plays a larger role during Mycobacterium tuberculosis in vitro dormancy and reactivation than previously suspected. Tuberculosis 103:1–9CrossRefGoogle Scholar
- Sun B, Zeng Q, Luo Z, Yang HJ, Feng Y (2017) Synthesis of (25R)-cholestenoic acid. Chin J Pharm 2017(48):174–178Google Scholar
- Vanderven BC, Fahey RJ, Lee W, Liu Y, Abramovitch RB, Memmott C, Crowe AM, Eltis LD, Perola E, Deininger DD (2015) Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium’s metabolism is constrained by the intracellular environment. PLoS Pathog 11(2):e1004679CrossRefGoogle Scholar